BD VEO Trademark

Trademark Overview

On Monday, March 6, 2017, a trademark application was filed for BD VEO with the United States Patent and Trademark Office. The USPTO has given the BD VEO trademark a serial number of 87360322. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 4, 2025. This trademark is owned by Becton, Dickinson and Company. The BD VEO trademark is filed in the Medical Instrument Products category with the following description:

insulin syringes and needles
bd veo

General Information

Serial Number87360322
Word MarkBD VEO
Filing DateMonday, March 6, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 4, 2025
Registration Number5633527
Registration DateTuesday, December 18, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2017

Trademark Statements

Pseudo MarkBECTON DICKINSON VEO
Goods and Servicesinsulin syringes and needles

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 4, 2025
Primary Code010
First Use Anywhere DateMonday, January 29, 2018
First Use In Commerce DateMonday, January 29, 2018

Trademark Owner History

Party NameBecton, Dickinson and Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFranklin Lakes, NJ 07417
Party NameBecton, Dickinson and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFranklin Lakes, NJ 07417
Party NameBecton, Dickinson and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFranklin Lakes, NJ 07417

Trademark Events

Event DateEvent Description
Thursday, March 9, 2017NEW APPLICATION ENTERED
Friday, March 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 11, 2017NOTICE OF PSEUDO MARK E-MAILED
Thursday, June 1, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, June 1, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 1, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2017PUBLISHED FOR OPPOSITION
Tuesday, May 30, 2017ASSIGNED TO EXAMINER
Thursday, June 1, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, June 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 10, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2018SOU EXTENSION 1 FILED
Tuesday, April 10, 2018SOU EXTENSION 1 GRANTED
Thursday, September 27, 2018USE AMENDMENT FILED
Tuesday, October 23, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 13, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 15, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2018SOU TEAS EXTENSION RECEIVED
Thursday, April 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 27, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, October 23, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 14, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 18, 2018REGISTERED-PRINCIPAL REGISTER
Friday, July 4, 2025CANCELLED SEC. 8 (6-YR)
Monday, December 18, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

needles syringes insulin